recombinant human insulin-like growth factor-1 (IGF-1)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for recombinant human insulin-like growth factor-1 (IGF-1), covering 2018-03-26 to 2018-03-26. Get the full timeline:
Most recent: Clinical Trial Update: Treatment of Rett Syndrome With Recombinant Human IGF-1 [Phase 2]